The impact of orthotopic neobladder vs ileal conduit urinary diversion after cystectomy on the survival outcomes in patients with bladder cancer: A propensity score matched analysis.

Abstract:

BACKGROUND:Bladder cancer (BCa) is the most common urinary malignancy. The standard surgical treatment for patients with muscle-invasive BCa is cystectomy plus urinary diversion. Ileal conduit (IC) or orthotopic neobladder (ON), which have different indications, are the most commonly performed urinary diversions. METHODS AND MATERIALS:We sampled 5480 BCa patients from the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2015. Kaplan-Meier method with the log-rank test was used to assess cancer-specific survival (CSS) and overall survival (OS). Univariate and multivariate Cox's proportional hazard model was conducted to evaluate the hazard ratio of cancer-specific mortality and all-cause mortality before and after propensity score matching (PSM). RESULTS:We identified 5480 patients who received radical cystectomy (RC) plus IC (n = 5071) or ON (n = 409) with a median follow-up period of 33 months (interquartile range, 13-78 months). Patients in the ON group tended to be male and younger, with a higher percentage of married individuals, early pathological T stage, lymphadenectomy, and non-radiotherapy (all P < .05). After 1:1 PSM, 409 matched pairs were selected. Univariate and multivariate analysis showed that the ON group had better CSS and OS probabilities than the IC group in the overall cohort [hazard ratio (HR): 0.692, 95% confidence intervals (CI): 0.576-0.831, P < .001; HR: 0.677, 95% CI: 0.579-0.793, P < .001 respectively]. However, subgroup analysis revealed that only patients with pathological T2 stage benefited from ON diversion after PSM in the context of CSS (P = .016) and OS (P <.001). CONCLUSIONS:Young, married, and male patients with early pathological T stage, especially T2 stage, were more suitable to receive RC plus ON surgery, which could improve their probability of survival.

journal_name

Cancer Med

journal_title

Cancer medicine

authors

Su X,Wu K,Wang S,Su W,Li C,Li B,Mao X

doi

10.1002/cam4.3404

subject

Has Abstract

pub_date

2020-10-01 00:00:00

pages

7590-7600

issue

20

issn

2045-7634

journal_volume

9

pub_type

杂志文章
  • Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma.

    abstract:OBJECTIVE:To develop and validate a preoperative nomogram to predict pathological locally advanced disease (pLAD) of clinically localized upper urinary tract urothelial carcinoma (UTUC) treated with extirpative surgery. METHODS:In total, 1101 patients with cN0M0 UTUC (development cohort, n = 604; validation cohort, n ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2988

    authors: Yoshida T,Kobayashi T,Kawaura T,Miyake M,Ito K,Okuno H,Murota T,Makita N,Kawakita M,Kawa G,Kitawaki T,Fujimoto K,Matsuyama H,Shiina H,Azuma H,Ogawa O,Kinoshita H,Matsuda T

    更新日期:2020-06-01 00:00:00

  • Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.

    abstract::Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor involved in both solid and hematological tumors. About 80% of ALK-positive anaplastic large-cell lymphoma (ALCL) cases are characterized by the t(2;5)(p23;q35) translocation, encoding for the aberrant fusion protein nucleophosmin (NPM)-ALK, whereas 5% of n...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.413

    authors: Fontana D,Ceccon M,Gambacorti-Passerini C,Mologni L

    更新日期:2015-07-01 00:00:00

  • Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.

    abstract:BACKGROUND:Vitamin D3 (VitD) deficiency is linked to increased incidence and worse survival in bladder cancer (BCa). In addition to cystectomy, patients are treated with cisplatin-based chemotherapy, however 30%-50% of patients do not benefit from this treatment. The effects of VitD deficiency on response to chemothera...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2119

    authors: Bunch BL,Ma Y,Attwood K,Amable L,Luo W,Morrison C,Guru KA,Woloszynska-Read A,Hershberger PA,Trump DL,Johnson CS

    更新日期:2019-05-01 00:00:00

  • A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer.

    abstract::Conventional preoperative chemotherapy regimens have only limited efficacy in hormone receptor positive (HR+) breast cancer and new approaches are needed. We hypothesized that capecitabine, which is effective in metastatic breast cancer, may be an active preoperative treatment for HR+ breast cancer. Women with HR+, HE...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.164

    authors: Tolaney SM,Jeong J,Guo H,Brock J,Morganstern D,Come SE,Golshan M,Bellon J,Winer EP,Krop IE

    更新日期:2014-04-01 00:00:00

  • Gene expression profiling upon (212) Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model.

    abstract::Recent studies have demonstrated that therapy with (212) Pb-TCMC-trastuzumab resulted in (1) induction of apoptosis, (2) G2/M arrest, and (3) blockage of double-strand DNA damage repair in LS-174T i.p. (intraperitoneal) xenografts. To further understand the molecular basis of the cell killing efficacy of (212) Pb-TCMC...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.132

    authors: Yong KJ,Milenic DE,Baidoo KE,Kim YS,Brechbiel MW

    更新日期:2013-10-01 00:00:00

  • Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis.

    abstract::Interferon-α2 reduces elevated blood cell counts and splenomegaly in patients with myeloproliferative neoplasms (MPN) and may restore polyclonal hematopoiesis. Its use is limited by inflammation-mediated toxicity, leading to treatment discontinuation in 10-30% of patients. Ruxolitinib, a potent anti-inflammatory agent...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1619

    authors: Mikkelsen SU,Kjaer L,Bjørn ME,Knudsen TA,Sørensen AL,Andersen CBL,Bjerrum OW,Brochmann N,Fassi DE,Kruse TA,Larsen TS,Mourits-Andersen HT,Nielsen CH,Pallisgaard N,Thomassen M,Skov V,Hasselbalch HC

    更新日期:2018-08-01 00:00:00

  • RIG-I promotes IFN/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma.

    abstract::RIG-I is associated with the occurrence and development of many tumors. However, the role of RIG-I in radiotherapy and chemotherapy in NPC has not been reported to date. In our study, RIG-I expression was significantly reduced in chemoradiotherapy-resistant NPC tissues and cells compared with that in therapy-sensitive...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2501

    authors: Jing D,Zhou W,Shen L,Zhang Q,Xie WT,Shen E,Li Z,Shen LF,Sun LQ

    更新日期:2019-10-01 00:00:00

  • Osteonecrosis of the jaw and survival of patients with cancer: a nationwide cohort study in Denmark.

    abstract::Osteonecrosis of the jaw (ONJ) is an adverse effect of bone-targeted therapies, which are used to prevent symptomatic skeletal events following bone malignancy. We examined the association between ONJ and survival among cancer patients treated with bone-targeted agents. Using nationwide registries and databases in Den...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1173

    authors: Corraini P,Heide-Jørgensen U,Schiødt M,Nørholt SE,Acquavella J,Sørensen HT,Ehrenstein V

    更新日期:2017-10-01 00:00:00

  • Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.

    abstract::Success of cancer vaccination is strongly hampered by immune suppression in the tumor microenvironment (TME). Interleukin (IL)-6 is particularly and highly produced by triple-negative breast cancer (TNBC) cells, and has been considered as an important contributor to immune suppression in the TME. Therefore, we hypothe...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.94

    authors: Singh M,Ramos I,Asafu-Adjei D,Quispe-Tintaya W,Chandra D,Jahangir A,Zang X,Aggarwal BB,Gravekamp C

    更新日期:2013-08-01 00:00:00

  • Detection of early stage ovarian cancer in a large community cohort.

    abstract:BACKGROUND:Although detecting ovarian cancer at early stage is a highly meaningful clinical goal, no studies have evaluated early stage disease presentation in a large community-based population and how it differs from that of late stage disease. METHODS:Electronic medical records were evaluated for women diagnosed wi...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2522

    authors: Suh-Burgmann EJ,Alavi M

    更新日期:2019-11-01 00:00:00

  • A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, especially in East Asia and China. Long noncoding RNAs (lncRNAs) are emerging as critical regulators that may be involved in the development and progression of cancers in humans. However, the contributions of lncRNAs to HCC development, m...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1180

    authors: Cui H,Zhang Y,Zhang Q,Chen W,Zhao H,Liang J

    更新日期:2017-12-01 00:00:00

  • Association of peripheral blood leukocyte KIBRA methylation with gastric cancer risk: a case-control study.

    abstract::KIBRA was reported to be involved in various types of cancer and can be detected in blood. The purpose of this study was to investigate the relationship between the status of KIBRA methylation in peripheral blood leukocytes and gastric cancer (GC) risk. A case-control study was carried out to evaluate the association ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1474

    authors: Zhang Y,Zhou H,Sun H,Chen J,Huang D,Han X,Ren X,Lin S,Fan Q,Tian W,Zhao Y

    更新日期:2018-06-01 00:00:00

  • Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.

    abstract::A number of lifestyle associated factors, such as high body mass index (BMI), low physical activity, and related metabolic disorders, are associated with increased risk of cancer at several sites. For urinary bladder cancer (BC), such studies show inconsistent results, which could result from inadequate adjustment for...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3060

    authors: Hektoen HH,Robsahm TE,Andreassen BK,Stenehjem JS,Axcrona K,Mondul A,Gislefoss RE

    更新日期:2020-06-01 00:00:00

  • Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).

    abstract:BACKGROUND:Metastatic germ cell tumor (mGCT) patients receiving chemotherapy have increased risk of life-threatening venous thromboembolism (VTE). Identifying VTE risk factors may guide thromboprophylaxis in this highly curable population. METHODS:Data were collected from mGCT patients receiving first-line platinum-ba...

    journal_title:Cancer medicine

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cam4.2674

    authors: Tran B,Ruiz-Morales JM,Gonzalez-Billalabeitia E,Patrikidou A,Amir E,Seidel C,Bokemeyer C,Fankhauser C,Hermanns T,Rumyantsev A,Tryakin A,Brito M,Fléchon A,Kwan EM,Cheng T,Castellano D,Garcia Del Muro X,Hamid AA,Ottavia

    更新日期:2020-01-01 00:00:00

  • Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection.

    abstract::Combined hepatocellular-cholangiocarcinoma (cHCC-CC) and intrahepatic cholangiocarcinoma (ICC) are classified into one category, but comparison of prognosis of the two carcinomas remains controversial. The aim of the current study was to investigate surgical outcomes for patients with ICC or cHCC-CC who underwent rese...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2495

    authors: Song P,Midorikawa Y,Nakayama H,Higaki T,Moriguchi M,Aramaki O,Yamazaki S,Aoki M,Teramoto K,Takayama T

    更新日期:2019-10-01 00:00:00

  • Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.

    abstract:PURPOSE:Isocitrate dehydrogenase 1 (IDH1) has been proven as a prognostic and predictive marker in glioblastoma (GBM) patients. The purpose was to preoperatively predict IDH mutation status in GBM using multiregional radiomics features from multiparametric magnetic resonance imaging (MRI). METHODS:In this retrospectiv...

    journal_title:Cancer medicine

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cam4.1863

    authors: Li ZC,Bai H,Sun Q,Zhao Y,Lv Y,Zhou J,Liang C,Chen Y,Liang D,Zheng H

    更新日期:2018-12-01 00:00:00

  • The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy era.

    abstract:BACKGROUND:Intensity-modulated radiotherapy (IMRT) provides excellent local control in nasopharyngeal carcinoma (NPC). We investigated whether simplifying 8th American Joint Committee on Cancer staging system T categories improves prognostic value. METHODS:We used 2191 NPC patients as a training set and 414 patients s...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2131

    authors: Tang LL,Liang SB,Huang CL,Zhang F,Xu C,Mao YP,Tian L,Lin AH,Li L,Sun Y,Ma J

    更新日期:2019-05-01 00:00:00

  • The prognostic value of immunoscore in patients with colorectal cancer: A systematic review and meta-analysis.

    abstract::The tumor immune infiltrate, as recently evaluated with the immunoscore methodology, has been reported to be related to colorectal cancer (CRC) progression. Nevertheless, results varied from different studies. A meta-analysis was conducted to solve this problem. We collected data from included studies to evaluate the ...

    journal_title:Cancer medicine

    pub_type: 杂志文章,meta分析

    doi:10.1002/cam4.1921

    authors: Sun G,Dong X,Tang X,Qu H,Zhang H,Zhao E

    更新日期:2019-01-01 00:00:00

  • The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.

    abstract::Nuclear receptor coactivator 1 (NCOA1) plays crucial roles in the regulation of gene expression mediated by a wide spectrum of steroid receptors such as androgen receptor (AR), estrogen receptor α (ER α), and estrogen receptor β (ER β). Therefore, dysregulations of NCOA1 have been found in a variety of cancer types. H...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1786

    authors: Wang L,Li W,Li K,Guo Y,Liu D,Yao Z,Lin X,Li S,Jiang Z,Liu Q,Jiang Y,Zhang B,Chen L,Zhou F,Ren H,Lin D,Zhang D,Yeung SJ,Zhang H

    更新日期:2018-10-01 00:00:00

  • Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is a heterogeneous malignancy with a high incidence and poor prognosis. Exploration of the underlying mechanisms and effective prognostic indicators is conducive to clinical management and optimization of treatment. The RNA-seq and clinical phenotype data of HCC were retrieved from The C...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3526

    authors: Zhang Q,Sun L,Zhang Q,Zhang W,Tian W,Liu M,Wang Y

    更新日期:2020-12-01 00:00:00

  • A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2-positive early breast cancer.

    abstract::Within PrefHer (NCT01401166), patients and healthcare professionals (HCPs) preferred subcutaneous (SC) over intravenous (IV) trastuzumab. We undertook a prospective, observational time and motion study to quantify patients' time in infusion chairs and active HCP time in PrefHer. Patients with HER2-positive early breas...

    journal_title:Cancer medicine

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/cam4.573

    authors: De Cock E,Pivot X,Hauser N,Verma S,Kritikou P,Millar D,Knoop A

    更新日期:2016-03-01 00:00:00

  • The histological characteristics and clinical outcomes of lung cancer in patients with combined pulmonary fibrosis and emphysema.

    abstract::Combined pulmonary fibrosis and emphysema (CPFE) is an important risk factor for lung cancer (LC), because most patients with CPFE are smokers. However, the histological characteristics of LC in patients with CPFE (LC-CPFE) remain unclear. We conducted this study to explore the clinicopathological characteristics of L...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.858

    authors: Zhang M,Yoshizawa A,Kawakami S,Asaka S,Yamamoto H,Yasuo M,Agatsuma H,Toishi M,Shiina T,Yoshida K,Honda T,Ito KI

    更新日期:2016-10-01 00:00:00

  • Rinsing sampling of core needle biopsy for flow cytometric analysis: A favorable method for lymphoma diagnosis.

    abstract:BACKGROUND:Conventional protocols utilize core needle biopsy (CNB) or fine needle aspiration (FNA) to produce cell suspension for flow cytometry (FCM) is a diagnostic challenge for lymphoid malignancies. We aim to develop an alternative CNB rinsing technique (RT) to produce cell suspension for FCM during this mini-inva...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3540

    authors: Chi PD,Liu YJ,Huang YH,Mao MJ,Wang Y,Li ZM,Li J

    更新日期:2020-12-01 00:00:00

  • Liquid biopsy by NGS: differential presence of exons (DPE) in cell-free DNA reveals different patterns in metastatic and nonmetastatic colorectal cancer.

    abstract::Next-generation sequencing (NGS) has been proposed as a suitable tool for liquid biopsy in colorectal cancer (CRC), although most studies to date have focused almost exclusively on sequencing of panels of potential clinically actionable genes. We evaluated the clinical value of whole-exome sequencing (WES) of cell-fre...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.1399

    authors: Olmedillas-López S,García-Olmo DC,García-Arranz M,Peiró-Pastor R,Aguado B,García-Olmo D

    更新日期:2018-05-01 00:00:00

  • Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and pancreatic cancer incidence and mortality: A prospective cohort study.

    abstract:BACKGROUND:Whether adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations is associated with a reduced risk of pancreatic cancer remains controversial. Additionally, no study has investigated this association in the US population. Hence, we inves...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.3348

    authors: Zhang ZQ,Li QJ,Hao FB,Wu YQ,Liu S,Zhong GC

    更新日期:2020-09-01 00:00:00

  • Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma?

    abstract::The association of bevacizumab and irinotecan has been shown to display a quick efficacy in low-grade glioma (LGG), but most patients relapse within months after cessation of therapy. From October 2012 to March 2014, four patients have been treated with irinotecan-bevacizumab followed by a metronomic maintenance with ...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.699

    authors: Heng MA,Padovani L,Dory-Lautrec P,Gentet JC,Verschuur A,Pasquier E,Figarella-Branger D,Scavarda D,André N

    更新日期:2016-07-01 00:00:00

  • TP53 mediated miR-3647-5p prevents progression of cervical carcinoma by targeting AGR2.

    abstract::Previous studies have shown that miRNAs involved in a number of biological processes, such as cell growth, development, differentiation, and apoptosis. The dysregulation of miRNA expression is associated with various diseases, including cervical cancer. However, the involvement of miR-3647-5p in the progression of tum...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2507

    authors: Liu R,Qian M,Zhou T,Cui P

    更新日期:2019-10-01 00:00:00

  • Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.

    abstract:BACKGROUND:Triple-negative apocrine carcinoma (TNAC) of the breast is a very rare type of breast cancer. Furthermore, the clinicopathological features, prognosis, and potential impact of treatment strategies in TNAC remain unclear. METHODS:Data from the Surveillance, Epidemiology, and End Results (SEER) program were u...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2634

    authors: Wu W,Wu M,Peng G,Shi D,Zhang J

    更新日期:2019-12-01 00:00:00

  • miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.

    abstract:PURPOSE:To investigate the effect of miR-107 on the growth and metastasis of gastric cancer (GC) and elucidate the probable mechanisms. METHODS:The expression of miR-107 and FAT4 in GC tissues and cells were detected using qRT-PCR. Bioinformatics and dual luciferase reporter gene assays were used to analyze the relati...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2396

    authors: Wang L,Li K,Wang C,Shi X,Yang H

    更新日期:2019-09-01 00:00:00

  • Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.

    abstract:BACKGROUND:The role of Axl and LC3 as predictors of tumor recurrence and overall survival (OS) after hepatocellular carcinoma (HCC) resection remains unclear. METHODS:We retrospectively included 535 HCC patients who underwent hepatectomy from 2010 to 2014 in this study. Axl and the autophagy-related marker LC3 were im...

    journal_title:Cancer medicine

    pub_type: 杂志文章

    doi:10.1002/cam4.2229

    authors: Hsu CC,Hsieh PM,Chen YS,Lo GH,Lin HY,Dai CY,Huang JF,Chuang WL,Chen YL,Yu ML,Lin CW

    更新日期:2019-07-01 00:00:00